Last10K.com

Accelrys, Inc. (ACCL) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2012

Accelrys, Inc.

CIK: 1002388 Ticker: ACCL


Exhibit 99.1
ACCELRYS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2012 RESULTS
Non-GAAP Revenue up 16% to $47.5 million in the Fourth Quarter

San Diego, February 26, 2013
- Accelrys, Inc. (NASDAQ: ACCL) today reported financial results for the fiscal quarter and year ended December 31, 2012, including a 16% year-over-year increase in Non-GAAP revenue in the fourth quarter.
Non-GAAP revenue for the quarter ended December 31, 2012 increased $6.7 million to $47.5 million from $40.8 million for the same quarter of the previous year, or an increase of 16%. Non-GAAP revenue for the year ended December 31, 2012 increased $19.3 million to $174.3 million from $155.0 million for the year ended December 31, 2011, or an increase of 12%.
Non-GAAP net income was $4.5 million, or $0.08 per diluted share, for the quarter ended December 31, 2012 compared to non-GAAP net income of $4.6 million, or $0.08 per diluted share, for the same quarter of the previous year. Non-GAAP net income was $19.6 million, or $0.35 per diluted share, for the year ended December 31, 2012 compared to non-GAAP net income of $19.0 million, or $0.34 per diluted share, for the year ended December 31, 2011.
GAAP revenue for the quarter ended December 31, 2012 increased $4.4 million to $44.2 million from $39.8 million for the same quarter of the previous year, or an increase of 11%. GAAP revenue for the year ended December 31, 2012 increased $18.2 million to $162.5 million from $144.3 million for the year ended December 31, 2011, or an increase of 13%.
GAAP net loss was $(8.2) million, or $(0.15) per diluted share, for the quarter ended December 31, 2012 compared to GAAP net income of $14.2 million, or $0.25 per diluted share, for the same quarter of the previous year. GAAP net loss was $(10.4) million, or $(0.19) per diluted share, for the year ended December 31, 2012 compared to GAAP net income of $1.8 million, or $0.03 per diluted share, for the same period of the previous year.
“We are pleased with our performance in both 2012 and against the three-year plan we developed for our business following our 2010 merger with Symyx. We achieved both market momentum and acknowledgment of our position as the leading provider of scientific innovation lifecycle management software,” said Max Carnecchia, President and CEO. “Performance in the fourth quarter of 2012 was strong as our revenues grew 16% over the prior year. In addition, we completed and are integrating three acquisitions key to our strategy of optimizing the lab-to-market value chain.  We remain enthusiastic about the market opportunity in front of us and in our ability to continue to grow orders, revenue and profits both organically and inorganically in 2013.”
Recent Business Highlights:

Completed three acquisitions that add important domain expertise and technology capabilities that further our strategy to optimize the innovation lifecycle from research through commercialization. 
HEOS, a secure Cloud-based information management workspace for scientific collaboration, accelerates and streamlines collaborative drug-discovery.
Aegis Analytical Corporation (Aegis), the leading provider of process management informatics software, further expands the footprint in downstream operation with solutions that help aggregate, contextualize and analyze manufacturing, quality and product development data.
Vialis AG, a leading systems integrator with deep experience implementing and supporting paperless laboratory solutions, further strengthening Accelrys' position in the laboratory informatics software market.

Delivered new product releases in the core product lines and significantly progressed the integration roadmap for the solutions acquired into the portfolio, including:
New Accelrys Enterprise Platform (AEP), the industry's first scientifically aware, service-oriented architecture (SOA) that enables integration and deployment of broad scientific solutions (Platform)
New biology capabilities from screening through pre-clinical development in the Accelrys Electronic Laboratory Notebook (Enterprise Lab Management)
New Process Management and Compliance suite, a unified approach to product development and process management which combines the capabilities of the Accelrys ELN, Accelrys Lab Execution System (LES), Accelrys Electronic Batch Records (EBR) and the Accelrys Enterprise Platform (Enterprise Lab Management)
New integration between Accelrys Materials Studio and AEP, enabling computational scientists to collaborate across the enterprise; deepened biotherapeutics capabilities in Accelrys Discovery Studio (Modeling and Simulation)



1

The following information was filed by Accelrys, Inc. (ACCL) on Tuesday, February 26, 2013 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Accelrys, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accelrys, Inc..

Continue

Assess how Accelrys, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accelrys, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (parenthetical)
Consolidated Statement Of Stockholder's Equity
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Operations
Business Combinations
Business Combinations (details)
Business Combinations (tables)
Business Combinations Symyx (details)
Commitments And Contingencies
Commitments And Contingencies (details)
Commitments And Contingencies (tables)
Commitments And Contingencies Royalties (details)
Fair Value
Fair Value (tables)
Fair Value Schedule Of Fair Value Assets And Liabilities Measured On A Recurring Basis (details)
Fair Value Schedule Of Fair Value Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation (details)
Goodwill And Purchased Intangible Assets
Goodwill And Purchased Intangible Assets (details)
Goodwill And Purchased Intangible Assets (tables)
Goodwill And Purchased Intangible Assets - Goodwill (details)
Guarantees
Guarantees (details)
Income Taxes
Income Taxes (tables)
Income Taxes - Continuing Operations (details)
Income Taxes - Federal Statutory Rate (details)
Income Taxes - Provision For Income Taxes (details)
Income Taxes Narrative (details)
Income Taxes Unrecognized Tax Benefit (details)
Inocome Taxes - Deferred Tax Assets And Liabilities (details)
Intermolecular (details)
Legal Proceedings
Long Term Investments And Promissory Notes Receivable
Long Term Investments And Promissory Notes Receivable Freeslate (details)
Marketable Securities
Marketable Securities (details)
Marketable Securities (policies)
Marketable Securities (tables)
Net Income (loss) Per Share
Net Income (loss) Per Share (details)
Net Income (loss) Per Share (tables)
Organization And Summary Of Signifiacnt Accounting Policies (tables)
Organization And Summary Of Significant Accounting Policies
Organization And Summary Of Significant Accounting Policies (policies)
Organization And Summary Of Significant Accounting Policies Expenses (details)
Organization And Summary Of Significant Accounting Policies Foreign Currency Translation And Share Based Compensation (details)
Organization And Summary Of Significant Accounting Policies Income Taxes (details)
Organization And Summary Of Significant Accounting Policies Property And Equipment (details)
Organization And Summary Of Significant Accounting Policies Segment And Geographic Information (details)
Organization And Summary Of Significant Accounting Policies Software Development Cost (details)
Restructuring Activities
Restructuring Activities (details)
Restructuring Activities (tables)
Retirement Savings Plans
Retirement Savings Plans (details)
Royalty And Other Income, Net
Royalty And Other Income, Net (details)
Royalty And Other Income, Net (tables)
Selected Quarterly Financial Information
Selected Quarterly Financial Information (details)
Selected Quarterly Financial Information (tables)
Share-based Payments
Share-based Payments (details)
Share-based Payments (tables)
Share-based Payments - Allocation Of Stock Compensation Expense And Treasury Stock Activity (details)
Share-based Payments - Valuation Assumptions Of Share-based Awards (details)
Subsequent Events
Subsequent Events (details)
Ticker: ACCL
CIK: 1002388
Form Type: 10-K Annual Report
Accession Number: 0001002388-13-000006
Submitted to the SEC: Wed Mar 06 2013 5:35:06 PM EST
Accepted by the SEC: Thu Mar 07 2013
Period: Monday, December 31, 2012
Industry: Prepackaged Software

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/accl/0001002388-13-000006.htm